Corrigendum to “Where do plasma biomarkers fit in with current Alzheimer’s disease detection?” [volume 33, issue 4, April 2025, pages 428–437]
Year: 2025
Type: erratum
Institution: University of Pittsburgh
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,400
Awards: The role of astrogliosis in aging and the pathological and clinical progression of Alzheimer's Disease, G2233774040, Roles of Gray Matter Brain Aging and Small Vessel Disease in AD Pathophysiology, G37801711, Subclinical vascular disease and AD pathology in the transition from midlife to old age, Investigating Gains in Neurocognition in an Intervention Trial of Exercise, Evaluation of Brain and Cognitive Changes in Older Adults with MCI Taking Lithium to Prevent Alzheimer Type Dementia, Aerobic Exercise for Optimizing Cognitive and Brain Health In Remitted Late-Life Depression, Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network, Intraindividual Cognitive Variability as an Early Marker of Alzheimer's Disease, Mild Cognitive Impairment: A Prospective Community Study, Alzheimer Disease Research Center, Longitudinal multicenter head-to-head harmonization of tau PET tracers, Head-to-head comparisons of high-performance plasma phospho-tau epitopes for the detection of Alzheimer's disease, Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood, Predictors of Altered CNS Structure, Function, and Connectomics in the Elderly using a Health Disparities Framework
OpenAlex ID: W4411715625